MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...

Integrated DNA Technologies (IDT), a global genomics provider headquartered in Coralville, is expanding its infectious ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...

A federal court has temporarily blocked the Trump administration from clawing back millions in public health funding from ...

Ten children died during the 2024-25 season, up from zero just five years ago. Experts say the spike comes as vaccination ...

Onradivir significantly shortens recovery time in adults with uncomplicated influenza A. Read more. Learn more.

On June 10th, the Guangzhou Laboratoryheld a press conference for Onradivir, unveiling the development process and advantages ...